Citron: 'The Real Problem With Drug Pricing In America Is Forged In A Single Word: Valeant'

By: via Benzinga
Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 15 percent on Monday. The decline was triggered ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.